SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029487
Filing Date
2022-08-15
Accepted
2022-08-15 16:02:59
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20220630.htm   iXBRL 10-Q 1784975
2 EX-31.1 cbio-ex311_9.htm EX-31.1 14100
3 EX-31.2 cbio-ex312_10.htm EX-31.2 14108
4 EX-32.1 cbio-ex321_7.htm EX-32.1 9718
5 EX-32.2 cbio-ex322_6.htm EX-32.2 9724
6 GRAPHIC gikpv1fixjdo000001.jpg GRAPHIC 38951
  Complete submission text file 0001564590-22-029487.txt   6396645

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220630.xsd EX-101.SCH 48068
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20220630_cal.xml EX-101.CAL 37278
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20220630_def.xml EX-101.DEF 112075
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220630_lab.xml EX-101.LAB 336628
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220630_pre.xml EX-101.PRE 242392
61 EXTRACTED XBRL INSTANCE DOCUMENT cbio-10q_20220630_htm.xml XML 1136542
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 221165598
SIC: 2834 Pharmaceutical Preparations